A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy
Titel:
A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy
Auteur:
Baik, Christina Lee, Sylvia Cook, Kitty Wallace, Sarah Wood, Rebecca Santana-Davila, Rafael Chow, Laura Rodriguez, Cristina Eaton, Keith D. Martins, Renato